[144] FirstCash Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

A holder of FCFS common stock has filed a notice of proposed sale under Rule 144 for 4,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $687,680.00. These shares relate to stock options previously exercised for cash on 10/21/2014. The notice states there were 44,134,150 common shares outstanding and targets an approximate sale date of 02/05/2026 on the NASDAQ exchange.

The filing also lists Rule 10b5-1 sales over the past three months by affiliated entities: the Robert Douglas Orr Jr. Irrevocable Trust sold 3,000 common shares for $474,513.00, the Jayne M Orr Irrevocable Trust sold 1,000 shares for $158,353.00, and Yellow Lab Properties, LP sold 1,500 shares for $237,784.05.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4000	687680.00	44134150	02/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/21/2014	Previously Exercised Stock Options	Issuer			4000	10/21/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ROBERT DOUGLAS ORR JR. IRRV TRUST 1600 West 7th Street Fort Worth TX 76102	Common	11/17/2025	3000	474513.00
10b5-1 Sales for JAYNE M ORR IRREVOCABLE TRUST 1600 West 7th Street Fort Worth TX 76102	Common	11/17/2025	1000	158353.00
10b5-1 Sales for YELLOW LAB PROPERTIES, LP 1600 West 7th Street Fort Worth TX 76102	Common	11/17/2025	1500	237784.05

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the FCFS Rule 144 notice disclose about upcoming share sales?

The notice discloses an intended sale of 4,000 FCFS common shares under Rule 144. The sale is planned through Morgan Stanley Smith Barney on NASDAQ, reflecting an aggregate market value of $687,680.00 and referencing previously exercised stock options acquired on October 21, 2014.

How many FCFS shares are planned for sale and what is their market value?

The filer plans to sell 4,000 FCFS common shares with an aggregate market value of $687,680.00. These shares will be sold through Morgan Stanley Smith Barney on NASDAQ, based on the market price at the time noted in the Rule 144 notice.

When is the approximate sale date for the FCFS shares in this Rule 144 filing?

The approximate sale date for the 4,000 FCFS common shares is listed as February 5, 2026. This planned timing appears in the securities information section, alongside the NASDAQ exchange designation and the aggregate market value of the proposed transaction.

What prior FCFS share sales over the last three months are reported in the filing?

The filing reports three recent sales: 3,000 shares by the Robert Douglas Orr Jr. Irrevocable Trust, 1,000 shares by the Jayne M Orr Irrevocable Trust, and 1,500 shares by Yellow Lab Properties, LP, all on November 17, 2025, under Rule 10b5-1 trading instructions.

What gross proceeds were generated by the recent FCFS insider-related share sales?

The recent sales generated gross proceeds of $474,513.00 for the Robert Douglas Orr Jr. Irrevocable Trust, $158,353.00 for the Jayne M Orr Irrevocable Trust, and $237,784.05 for Yellow Lab Properties, LP. All three transactions involved FCFS common shares sold on November 17, 2025.

How were the 4,000 FCFS shares originally acquired before this planned Rule 144 sale?

The 4,000 FCFS common shares were acquired on October 21, 2014 through previously exercised stock options. The purchase was paid in cash on the same date, as indicated in the acquisition and payment section of the Rule 144 notice.